In November last year, the House of Representatives Standing Committee on Health, Aged Care and Sport delivered its bipartisan report “The New Frontier: Delivering better health for all Australians” on the approval processes for new drugs and novel medical technologies in Australia.
Australian Health Journal spoke to some of the industry bodies who were part of the Inquiry, for their comments on the process, the report and hopes in the recommendations being implemented.
Professor John Zalcberg OAM Australian Clinical Trials Alliance (ACTA) Board Director & former ACTA Board Chair
Shanny Dyer, Chief Executive Officer, ARCS Australia
Leanne Wells, Chief Executive Officer, Consumers Health Forum of Australia
Liz de Somer, Chief Executive Officer Medicines Australia
Ian Burgess, Chief Executive Officer,
Medical Technology Association of Australia
Watch Season 5, Australian Health Journal Episode S5E1
-
Tasmanian researchers and clinicians working together
Tasmanian medical research charity funds projects that have a global impact and improve community health and well-being.
Australian Health Journal spoke to Stephanie Furler the Chief Executive Officer of The Royal Hobart Hospital Research Foundation about the impact of this research locally and in global health.
-
Elevating Professional Standards in the Medtech and Pharmaceutical Sector
ARCS Australia Ltd, the peak body representing professionals in the MedTech and Pharmaceutical sector, this week announced a series of significant changes at its annual conference.
Dr Tim Boyle, CEO of ARCS Australia Ltd speaking to Australian Health Journal says, “These initiatives are central to strategy to build professionalism within the sector, increase capability and enhance the professional standing of its members.”
-
Cardiologist broadens Tasmania’s surgical abilities
Dr Heath Adams is a Tasmanian born, bred and educated interventional and structural cardiologist who works at Hobart Private and Royal Hobart Hospital and is a researcher through the Menzies Research Institute.
Dr Adams clinical interest and expertise is in the management of aortic stenosis, valvular heart disease and acute coronary syndromes. Dr Adams performs coronary interventions including stenting, and structural heart interventions including TAVI, mitral edge to edge repair, mitral valve replacement and left atrial appendage closure. In 2020, Heath performed the first TAVI in Tasmania, is the clinical lead for the local program at the Royal Hobart Hospital and is a nationally accredited TAVI practitioner.
